Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

RNAC Cartesian Therapeutics Inc

10,11

0,11 (1,10%)

08 Apr 2025 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Cartesian Therapeutics (NASDAQ:RNAC)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Cartesian Therapeutics Charts.

Cartesian Therapeutics (NASDAQ:RNAC)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Cartesian Therapeutics Charts.

News Cartesian Therapeutics Inc

Cartesian Therapeutics Announces New Employment Inducement Grants
Mittwoch 2 April 2025 (6 Tage vor) • GlobeNewswire Inc.

Cartesian Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Dienstag 1 April 2025 (7 Tage vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 13 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 13 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Donnerstag 13 März 2025 (4 Wochen vor) • GlobeNewswire Inc.

Cartesian Therapeutics Announces New Employment Inducement Grant
Donnerstag 6 März 2025 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 3 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Dienstag 18 Februar 2025 (2 Monate vor) • GlobeNewswire Inc.

Cartesian Therapeutics Announces New Employment Inducement Grants
Donnerstag 6 Februar 2025 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 27 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

Cartesian Therapeutics Announces FDA Special Protocol Assessment Agreement for Phase 3 AURORA Trial of Descartes-08 in Myasthenia Gravis
Montag 27 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Dienstag 14 Januar 2025 (3 Monate vor) • Edgar (US Regulatory)

Weitere Cartesian Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen